Novel N- (fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4.

Details for Australian Patent Application No. 2006325573 (hide)

Owner AstraZeneca AB

Inventors Roberts, Bryan; Kindon, Nicholas; Mete, Antonio; Cheshire, David

Agent Freehills

Pub. Number AU-A-2006325573

PCT Pub. Number WO2007/069978

Priority 0502733-9 12.12.05 SE

Filing date 11 December 2006

Wipo publication date 21 June 2007

International Classifications

C07D 241/22 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

12 June 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read: Novel N- (fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4.

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/069978 Priority application(s): WO2007/069978

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006325574-Microwave heating applicator

2006325572-Alkylsulphonamide quinolines